Related Experiment Videos
Cervical cancer screening in Japan. A case-control study
1Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.
Acta Cytologica
|July 1, 1997
Summary
Mass screening using cervical cytologic smears significantly improves cervical cancer detection in Japan. This study confirms the effectiveness of regular screening intervals for early diagnosis and intervention.
Area of Science:
- Oncology
- Public Health
- Gynecologic Pathology
Background:
- Cervical cancer remains a significant public health concern globally.
- Early detection through screening is crucial for improving patient outcomes.
- Cervical cytologic smears are a primary tool for cervical cancer screening.
Purpose of the Study:
- To evaluate the effectiveness of mass screening for cervical cancer using cytologic smears in Japan.
- To determine the association between prior screening and the risk of invasive cervical cancer.
- To analyze the impact of screening intervals on invasive cervical cancer detection.
Main Methods:
- A case-control study involving 109 patients with invasive cervical cancer identified through mass screening (1984-1989).
- Age-matched controls were selected from females undergoing screening in the same period and district.
- Odds ratios (OR) were calculated for invasive cervical cancer and histologic subtypes based on screening status and interval.
Main Results:
- A significant odds ratio for invasive cervical cancer was observed in previously screened versus unscreened females (P < .16).
- Squamous cell carcinoma showed a significant OR for previously screened individuals (P < .14), unlike adenocarcinoma (P < .45).
- Significant ORs were found for screening intervals of one year (P < .11) and two years (P < .33).
Conclusions:
- This case-control study provides statistical evidence for the utility of cervical cancer screening in Japan.
- Regular screening, particularly at one- or two-year intervals, is associated with a reduced risk of invasive cervical cancer.
- The findings support the continued implementation and optimization of mass screening programs for cervical cancer.